These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 29762954)
1. A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases. Sharma PK; Singh DK Indian J Lepr; 2016 Sep; 87(4):249-253. PubMed ID: 29762954 [TBL] [Abstract][Full Text] [Related]
10. Florid reactive periostitis ossificans of long bones and digits associated with reaction in a patient with leprosy. Chakma JK; Malaviya GN; Girdhar A; Hussein S Lepr Rev; 2012 Mar; 83(1):98-103. PubMed ID: 22655475 [TBL] [Abstract][Full Text] [Related]
11. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions. Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962 [TBL] [Abstract][Full Text] [Related]
12. Possible incompatibility of dapsone with clofazimine in the treatment of patients with erythema nodosum leprosum. Imkamp FM; Anderson R; Gatner EM Lepr Rev; 1982 Jun; 53(2):148-9. PubMed ID: 7098753 [No Abstract] [Full Text] [Related]
13. [Chemotherapy of Hansen's disease in Japan--present status]. Goto M; Miyagi S; Takizawa H; Kitajima S Nihon Hansenbyo Gakkai Zasshi; 1998 Jul; 67(2):305-11. PubMed ID: 9785846 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for erythema nodosum leprosum. Manandhar R; LeMaster JW; Roche PW Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406 [TBL] [Abstract][Full Text] [Related]
15. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient. Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470 [TBL] [Abstract][Full Text] [Related]
17. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT. Balagon M; Saunderson PR; Gelber RH Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929 [TBL] [Abstract][Full Text] [Related]
18. Combined regimens of one year duration in the treatment of multibacillary leprosy--II. Combined regimens with rifampicin administered during 6 months. Pattyn SR; Groenen G; Janssens L; Deverchin J; Ghys P Lepr Rev; 1989 Jun; 60(2):118-23. PubMed ID: 2671560 [TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of levamisole in leprosy. Sharma L; Thalliath GH; Girgia HS; Sen PC Indian J Lepr; 1985; 57(1):11-6. PubMed ID: 3839808 [TBL] [Abstract][Full Text] [Related]
20. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]